Oaktree Acquisition Corp. III Life Sciences
OACC- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002029769
No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 51 institutions reported holding it in 13F filings for Q2 2026, worth $181.5M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Oaktree Acquisition Corp. III Life Sciences changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 0 | 20 | +20 |
| Shares | 0 | 8.99M | +8.99M |
| Value | $0 | $89.8M | +$89.8M |
New holders (20)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CNH Partners LLC | 1,980,285 | $19.7M | 0.47% |
| Toronto Dominion Bank | 1,436,900 | $14.4M | 0.03% |
| Boussard & Gavaudan Investment Management LLP | 750,000 | $7.60M | 0.63% |
| Decagon Asset Management LLP | 709,930 | $7.07M | 3.23% |
| Shaolin Capital Management LLC | 550,000 | $5.48M | 0.17% |
| Highbridge Capital Management LLC | 450,000 | $4.50M | 0.17% |
| UBS Oconnor LLC | 450,000 | $4.48M | 0.11% |
| Two Sigma Investments, LP | 437,500 | $4.36M | 0.01% |
| Gritstone Asset Management LLC | 400,000 | $3.98M | 4.22% |
| Lighthouse Investment Partners, LLC | 300,000 | $3.04M | 0.12% |
| Tenor Capital Management Co., L.P. | 300,000 | $2.99M | 0.04% |
| ExodusPoint Capital Management, LP | 300,000 | $2.99M | 0.03% |
| Sculptor Capital LP | 250,000 | $2.49M | 0.04% |
| Verition Fund Management LLC | 200,000 | $2.00M | 0.01% |
| K2 Principal Fund, L.P. | 195,292 | $1.95M | 0.29% |
| DLD Asset Management, LP | 175,000 | $1.74M | 0.30% |
| Fir Tree Capital Management LP | 45,800 | $457.5K | 1.07% |
| Levin Capital Strategies, L.P. | 23,000 | $229.8K | 0.02% |
| Virtu Financial LLC | 20,257 | $202.0K | 0.01% |
| Clear Street LLC | 16,072 | $160.1K | 0.00% |
Sold out (0)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q3 2024 and filed for Q4 2024 without it.
None.